A Phase 1a/1b Dose Escalation, Dose Expansion Study of SW-682 in Participants With Advanced Solid Tumors Enriched for Those With Hippo Pathway Mutations
NCT06251310 · RECRUITING · Phase 1
We track 1 ClinicalTrials.gov studies led by Springworks Therapeutics Inc. The portfolio skews toward Phase 1 (1 trials).
1 clinical trials sponsored by Springworks Therapeutics Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
Springworks Therapeutics Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.
Springworks Therapeutics Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Springworks Therapeutics Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.